Clinical trial
Biomarkers of the Locus Coeruleus Nucleus: Links With Early Tau Pathology, Cognition and Alzheimer's Disease Risk.
NCT07007208 is registered in ClinicalTrials.gov with University Hospital, Toulouse as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Biomarkers of the Locus Coeruleus Nucleus: Links With Early Tau Pathology, Cognition and Alzheimer's Disease Risk.
- Lead sponsor
- University Hospital, Toulouse
- Phase
- Phase 2
- Overall status
- Recruiting
- Start date
- February 2, 2026
- Completion date
- January 31, 2029
- Enrollment
- 100 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.